Ru(II) complexes with enaminone structures for rapid sterilization of S. aureus and MRSA with little accumulation of drug resistance

Yao Jian,Yatong Peng,Wanpeng Zhou,Yunli Xu,Chao Li,Xuesong Wang,Qianxiong Zhou
DOI: https://doi.org/10.1002/cmdc.202300065
IF: 3.54
2023-02-08
ChemMedChem
Abstract:Drug‐resistant bacteria, such as methicillin‐resistant Staphylococcus aureus (MRSA), pose a serious threat to human life. Therefore, it is urgently desired to develop novel antibiotics with new chemical structures and antibacterial mechanisms, especially those eliciting little drug resistance after long‐time usage. Herein we synthesized three novel ruthenium complexes (Ru1‐Ru3) containing the enaminone structures for the first time. 5 μM of Ru1‐Ru3 can lead to a CFU reduction of about 5 log units towards S. aureus and MRSA. Interestingly, Ru3 displayed rapid bactericidal effects and could decrease the CFU numbers of both pathogens by 5 log units within 40 min. The control compounds (Ru4 and Ru5) without the enaminone structures displayed very poor antibacterial activity under the same conditions. Moreover, S. aureus did not show apparent drug resistance towards Ru3 after 20 passages' incubation with a sublethal concentration. These results highlight the critical role of enaminone structures for antibacterial applications.
pharmacology & pharmacy,chemistry, medicinal
What problem does this paper attempt to address?